Aging

Aging : Aging (Albany NY) (by Medline/PubMed), Aging-US (by Web of Science)

The NEW Impact Factor is 5.955
It has increased from 5.682 (last year) to 5.955 (now)

Aging publishes research papers in all fields of aging research including but not limited, aging from yeast to mammals, cellular senescence, age-related diseases such as cancer and Alzheimer’s diseases and their prevention and treatment, anti-aging strategies and drug development and especially the role of signal transduction pathways such as mTOR in aging and potential approaches to modulate these signaling pathways to extend lifespan.
The journal aims to promote treatment of age-related diseases by slowing down aging, validation of anti-aging drugs by treating age-related diseases, prevention of cancer by inhibiting aging. Cancer and COVID-19 are age-related diseases.

Aging is indexed by PubMed/Medline abbreviated as “Aging (Albany NY)”, PubMed Central, ISI/Web of Science: Science Citation Index Expanded (abbreviated as Aging‑US and listed in the Cell Biology category; since June 2017 it has also been listed in the Geriatrics & Gerontology category), and Scopus (abbreviated as Aging).

Impact Journals, LLC meets the Wellcome Trust Publisher Requirements, and is now a member of the Wellcome Trust List of Compliant Publishers.
Impact Journals, LLC is a member of the Society for Scholarly Publishing.

This Month's Popular DOIs (Crossref Data)

Most popular Aging DOIs, measured by the number of times each DOI was successfully resolved.

Elizabeth Blackburn, a member of the Editorial Board of Aging, won the Nobel Prize in Physiology or Medicine 2009, while being a member of the board. Elizabeth Blackburn co-authored a paper published in the first (inaugural) issue of Aging.
Andrew V. Schally, Nobel Prize Laureate, published his paper in Aging.
Shinya Yamanaka won the Nobel Prize in Physiology and Medicine 2012. Shinya Yamanaka co-authored a paper published in Aging.